Colorectal Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age between 18 and 75 years, inclusive. 2.Scheduled for a screening, diagnostic, or surveillance colonoscopy. 3.Able to understand the study protocol and provide written informed consent.
Exclusion criteria
Exclusion criteria: 1.Known contraindications to colonoscopy or biopsy. 2.Personal history of colorectal cancer, inflammatory bowel disease (IBD), or previous colorectal surgery. 3.Known or suspected colorectal polyposis syndrome (e.g., Familial Adenomatous Polyposis - FAP). 4.Patients with active colorectal bleeding, bowel obstruction, or toxic megacolon. 5.Women who are pregnant, planning to become pregnant, or are breastfeeding. 6.Participation in another interventional clinical trial within the 30 days prior to enrollment. 7.Any other condition that, in the investigator's judgment, would make the participant unsuitable for the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adenoma Detection Rate (ADR); | — |
Secondary
| Measure | Time frame |
|---|---|
| Mean Adenomas Per Colonoscopy (APC);Physician Satisfaction Score;Patient Satisfaction Score;Advanced Adenoma and Sessile Serrated Adenoma/Polyp (SSA/P) Detection Rate;Incidence of Procedure-Related Adverse Events; | — |
Countries
China
Contacts
The second affiliated hospital of Zhejiang University school of medicine